FDA outlines steps for individualized drug development

被引：0

|

作者：

Asher Mullard

机构：

来源：

Nature Reviews Drug Discovery | 2021年 / 20卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[1] FDA outlines steps for individualized drug development
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (02) : 91 - 91
[2] DRUG PROMOTION - FDA STEPS IN
BUDIANSKY, S
NATURE, 1982, 298 (5877) : 784 - 785
[3] FDA outlines conditions for pharmacies to repackage drug products
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (07) : 453 - 455
[4] FDA announces steps to increase efficiency in preliminary stages of innovative drug development
不详
JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (03) : 110 - 110
[5] US FDA reports new steps in drug safety
Reactions Weekly, 2007, 1138 (1) : 3 - 3
[6] FDA AND NEW DRUG DEVELOPMENT
JAROWSKI, CI
DRUG & COSMETIC INDUSTRY, 1971, 108 (01): : 32 - &
[7] GOVERNMENT REGULATIONS AND DRUG DEVELOPMENT - FDA
JENNINGS, J
ADVANCES IN CHEMISTRY SERIES, 1971, (108): : 247 - &
[8] An FDA perspective on the drug development process
Woodcock, J
FOOD AND DRUG LAW JOURNAL, 1997, 52 (02): : 145 - 150
[9] FDA Regulations for Drug Development Response
Levinson, Arthur D.
SCIENCE, 2010, 329 (5987) : 33 - 33
[10] The FDA and IBS Drug Development Reply
Talley, Nicholas J.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (12): : 3106 - 3106

← 1 2 3 4 5 →